Michael Engelbrecht

Background

About Michael Engelbrecht

Professional Summary Current Role: Based on the Gold Coast, Queensland since September 2014 with AstraZeneca. Achievements Chronic Care GP Representative of the Year: Awarded in both 2022 and 2023, recognizing excellence in the chronic care segment. Representative of the Year (Cardiovascular Franchise): Honored in 2011 for outstanding performance in the cardiovascular market. 5-Year Service Award: Received in August 2012 during tenure at Sanofi. Contribution Awards (Vioxx & Cozaar): Recognized in 2002 for significant contributions to the Vioxx and Cozaar brands. Growth Recognition Award (Vioxx): Awarded in 2002 for exceptional growth in the Vioxx product line. Highest National Growth (Vioxx): Achieved in May 2003 for leading national sales growth. Outstanding Achievement Awards: Earned for exceptional performance with Fortzaar and Cozaar. Industry Experience Pharmaceutical/Medical Sales: Over 20 years of experience, with a diverse portfolio including work at Sanofi, Johnson & Johnson (Ethicon Endo), Merck & Co (MSD), and GlaxoSmithKline. Sanofi Experience- Specialized in clones of originator products within the Zentiva Division, across therapeutic areas such as anticoagulants, anti-arrhythmics, epilepsy, hypertension, antipsychotics, asthma, and antibiotics- Previous roles included working in the cardiovascular, insulin-dependent/oral diabetic, and hypnotic markets. Prescription Drug Markets: Extensive experience in respiratory (allergic rhinitis/asthma), pain/rheumatology, and osteoporosis markets. Medical Device Industry: Experienced in laparoscopic surgery, with involvement in both private and government sectors